原著論文1
Tominaga K, Miyano S, & Gotoh N. et al
Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
Oncogene
, 36
, 1276-1286
(2017)
doi: 10.1038/onc.2016.293
原著論文2
Nakata A, Miyano S, & Gotoh N. et al
Elevated beta-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs.
Sci Rep
, 5
, 13076-
(2015)
doi: 10.1038/srep13076
原著論文3
Otsubo C., Gotoh N. & Enari M. et al.
Chihiro Otsubo, Jun Yokota, and Masato Enari et al.
Cell Reports
, 7
(2)
, 527-538
(2014)
原著論文4
Gotoh N.
Growth factor signaling regulates breast cancer stem cells. In Practical molecular target for suppression of cancer. Publication in Forum on Immunopathological Diseases and Therapeutics, Begell House Inc.
Publisher, CT, USA
, 4
, 1-10
(2013)
原著論文5
Gotoh, N, Tanaka S. & Noguchi M. et al.
Protooncogene TCL1b functions as an Akt kinase co-activator which exhibits oncogenic potency in vivo
Oncogenesis
, 2
, e70-
(2013)
10.1038/oncsis.2013.30.
原著論文6
Kuroda M, Hattori S. & Gotoh N. et al
An adaptor protein complex of FRS2beta and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation.
Cancer Sci.
, 104
, 345-352
(2013)
原著論文7
Ohata, H., Gotoh N. & Enari, M. et al.
NuMA is required for the selective induction of p53 target genes.
Molecular and Cellular Biology
, 33
, 2447-2457
(2013)
原著論文8
Yokota, J., Miyano, S. & Gotoh, N. et al.
Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma.
PLoS ONE
, 7
, e43923-
(2012)
10.1371/journal.pone.0043923
原著論文9
Nakata, A. & Gotoh, N.
Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer.
Expert Opin. Ther. Targets
, 16
, 771-781
(2012)
原著論文10
Inoue J, Tojo A. & Gotoh N et al.
ErbB/NF-kB signaling controls mammosphere formation in human breast cancer.
Proc. Natl. Acad. Sci., USA
, 109
, 6584-6589
(2012)
原著論文11
Gotoh, N., Miyano, S. & Yokota, J. et al.
Identification of genes up-regulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinoma.
Cancer Res.
, 72
, 100-111
(2012)
原著論文12
Gotoh, N., Marko-Varga, G. & Nishimura, T. et al.
Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung.
Journal of Clinical Bioinformatics,
, 1
(23)
(2011)
10.1186/2043-9113-1-23.
原著論文13
Yamauchi, M., Yoshino, I. & Gotoh, N. et al
N-cadherin expression is a potential survival mechanism of gefitinib-resistant lung cancer cells.
Am. J. Cancer. Res.
, 1
, 823-833
(2011)
原著論文14
Gotoh, N.
Somatic mutations of the EGF receptor and their signal transducers affect the efficacy of EGF receptor-specific tyrosine kinase inhibitors.
Int. J. Clin. Exp. Pathol.
, 4
, 403-409
(2011)
原著論文15
Murohashi, M., Hinohara, K. & Gotoh, N. et al
Gene set enrichment analysis provides insight into novel signaling pathways in breast cancer stem cells.
British J. Cancer
, 102
, 206-212
(2010)
原著論文16
Hinohara, K. & Gotoh, N.
Inflammatory signaling pathways in self-renewing breast cancer stem cells.
Curr. Opin. Pharmacol.
, 10
, 650-654
(2010)
原著論文17
Iejima, D., Minegichi, Y. & Gotoh, N. et al
FRS2b, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor for EGF receptor family members via ERK binding.
Oncogen
, 29
, 3087-3099
(2010)
